Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Stedman

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Cardiovascular Endocrinology & Metabolism|September 12, 2022
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic healthUnaiza Waheed, Mike Stedman, Mark Davies, et al.
International Journal of Clinical Practice|March 15, 2018
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Adrian H Heald, Mark Livingston, Zuzanna Bien, et al.
The Primary Care Companion for CNS Disorders|January 22, 2020
Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in EnglandAdrian H Heald, Mike Stedman, Mark Davies, et al.
Human Psychopharmacology|June 5, 2020
Influences on the use of antidepressants in primary care: All England general practice-level analysis of demographic, practice-level and prescriber factorsAdrian H Heald, Mike Stedman, Mark Davies, et al.
International Journal of Clinical Practice|December 6, 2018
Demographic factor clustering at a GP practice level in England and its relation to glycaemic outcomes: What we can learn from thisMike Stedman, Mark Lunt, Mark Livingston, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes AuditAdrian H Heald, Mark Livingston, Nagaraj Malipatil, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 21, 2025
Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population-based study in Salford, ManchesterHellena Hailu Habte-Asres, Mike Stedman, Angus Forbes, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 9, 2025
Improving Diabetes Monitoring in People with Sub-optimally Controlled Diabetes: Implementing a Clinical Laboratory-Led Quality Improvement Initiative in General PracticeDavid Holland, Ian Halsall, Adrian H Heald, et al.
International Journal of Clinical Practice|July 22, 2021
Age of people with type 2 diabetes and the risk of dying following SARS-CoV-2 infectionZixing Tian, Adrian H Heald, Mike Stedman, et al.
Cardiovascular Endocrinology & Metabolism|November 23, 2020
Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics dataAdrian H Heald, Mike Stedman, Mark Davies, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Cardiovascular Endocrinology & Metabolism|September 12, 2022
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic healthUnaiza Waheed, Mike Stedman, Mark Davies, et al.
International Journal of Clinical Practice|March 15, 2018
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17Adrian H Heald, Mark Livingston, Zuzanna Bien, et al.
The Primary Care Companion for CNS Disorders|January 22, 2020
Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in EnglandAdrian H Heald, Mike Stedman, Mark Davies, et al.
Human Psychopharmacology|June 5, 2020
Influences on the use of antidepressants in primary care: All England general practice-level analysis of demographic, practice-level and prescriber factorsAdrian H Heald, Mike Stedman, Mark Davies, et al.
International Journal of Clinical Practice|December 6, 2018
Demographic factor clustering at a GP practice level in England and its relation to glycaemic outcomes: What we can learn from thisMike Stedman, Mark Lunt, Mark Livingston, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes AuditAdrian H Heald, Mark Livingston, Nagaraj Malipatil, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 21, 2025
Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population-based study in Salford, ManchesterHellena Hailu Habte-Asres, Mike Stedman, Angus Forbes, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 9, 2025
Improving Diabetes Monitoring in People with Sub-optimally Controlled Diabetes: Implementing a Clinical Laboratory-Led Quality Improvement Initiative in General PracticeDavid Holland, Ian Halsall, Adrian H Heald, et al.
International Journal of Clinical Practice|July 22, 2021
Age of people with type 2 diabetes and the risk of dying following SARS-CoV-2 infectionZixing Tian, Adrian H Heald, Mike Stedman, et al.
Cardiovascular Endocrinology & Metabolism|November 23, 2020
Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics dataAdrian H Heald, Mike Stedman, Mark Davies, et al.
Pageof 7